6.
Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim J
. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019; 574(7777):264-267.
PMC: 6858566.
DOI: 10.1038/s41586-019-1608-2.
View
7.
Bagchi S, Yuan R, Engleman E
. Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance. Annu Rev Pathol. 2020; 16:223-249.
DOI: 10.1146/annurev-pathol-042020-042741.
View
8.
Banerjee S, Tian T, Wei Z, Shih N, Feldman M, Peck K
. Distinct Microbial Signatures Associated With Different Breast Cancer Types. Front Microbiol. 2018; 9:951.
PMC: 5962706.
DOI: 10.3389/fmicb.2018.00951.
View
9.
Baruch E, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L
. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2020; 371(6529):602-609.
DOI: 10.1126/science.abb5920.
View
10.
Bender M, McPherson A, Phelps C, Pandey S, Laughlin C, Shapira J
. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell. 2023; 186(9):1846-1862.e26.
PMC: 10148916.
DOI: 10.1016/j.cell.2023.03.011.
View
11.
Bergsten E, Mestivier D, Donnadieu F, Pedron T, Barau C, Tsoumtsa Meda L
. , an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes. Gut Microbes. 2023; 15(2):2265138.
PMC: 10580862.
DOI: 10.1080/19490976.2023.2265138.
View
12.
Boursi B, Mamtani R, Haynes K, Yang Y
. Recurrent antibiotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota?. Eur J Cancer. 2015; 51(17):2655-64.
PMC: 4663115.
DOI: 10.1016/j.ejca.2015.08.015.
View
13.
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F
. A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009; 10(4):321-2.
DOI: 10.1016/s1470-2045(09)70096-8.
View
14.
Brechot C
. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology. 2004; 127(5 Suppl 1):S56-61.
DOI: 10.1053/j.gastro.2004.09.016.
View
15.
Brestoff J, Artis D
. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol. 2013; 14(7):676-84.
PMC: 4013146.
DOI: 10.1038/ni.2640.
View
16.
Byndloss M, Olsan E, Rivera-Chavez F, Tiffany C, Cevallos S, Lokken K
. Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion. Science. 2017; 357(6351):570-575.
PMC: 5642957.
DOI: 10.1126/science.aam9949.
View
17.
Byrd D, Vogtmann E, Wu Z, Han Y, Wan Y, Clegg-Lamptey J
. Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study. Int J Cancer. 2021; 148(11):2712-2723.
PMC: 8386185.
DOI: 10.1002/ijc.33473.
View
18.
Cameron S, Lewis K, Huws S, Hegarty M, Lewis P, Pachebat J
. A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer. PLoS One. 2017; 12(5):e0177062.
PMC: 5444587.
DOI: 10.1371/journal.pone.0177062.
View
19.
Cao Y, Wu K, Mehta R, Drew D, Song M, Lochhead P
. Long-term use of antibiotics and risk of colorectal adenoma. Gut. 2017; 67(4):672-678.
PMC: 5628103.
DOI: 10.1136/gutjnl-2016-313413.
View
20.
Casasanta M, Yoo C, Udayasuryan B, Sanders B, Umana A, Zhang Y
. host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration. Sci Signal. 2020; 13(641).
PMC: 7454160.
DOI: 10.1126/scisignal.aba9157.
View